Ludioman, Juvy .
HRN: 24-94-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/12/2024
CEFTRIAXONE 1G (VIAL)
04/12/2024
04/19/2024
IV
2 Grams
OD
Massive Pleural Effusion Prob Sec To Parapneumonic Process Vs Ptb
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes